Module

Does Polypharmacy Increase the Likelihood of Renal Toxicity Among Persons With HIV?

Source: The Evolving Management of Drug-Drug Interactions in HIV Infection

Does Polypharmacy Increase the Likelihood of Renal Toxicity Among Persons With HIV?

Faculty:

Lynda Szczech, MD, MSCE, FASN

CREDIT INFORMATION

Release Date: June 25, 2009

Expiration Date: June 24, 2010

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Status: The activity is not currently available for credit.

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the frequency of acute kidney injury in patients taking a tenofovir-containing antiretroviral regimen
Identify medications associated with increased risk of acute kidney injury
List the factors that may contribute to the risk of renal toxicity in patients on antiretroviral therapy

Abstract

Click here to view abstract

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.